© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Signos Wins Clearance for First Over-The-Counter CGM for Weight Management
August 25, 2025
The combination of the Dexcom Stelo glucose biosensor with an AI platform provides real-time data on how food, exercise, stress, and sleep affect the body.
ACOG Publishes Revised Guidance on Maternal Immunization for COVID-19, Influenza, and RSV
August 25, 2025
ACOG CEO: “In the face of misinformation and vaccine hesitancy, a strong, evidence-based recommendation...from a trusted clinician can go a long way."
Mediterranean Diet Linked to Reduced Risk of Dementia, Especially in Groups With High Genetic Risk
August 25, 2025
The protective effect of the diet was strongest in the highest-risk group, those homozygous for the APOE4 gene variant, suggesting that diet may help offset genetic risk.
Adults Visiting the ED Are Willing to Receive Missing CDC-Recommended Vaccines, Survey Finds
August 22, 2025
More than 90% of adults making nonurgent ED visits had missed at least 1 CDC-recommended vaccine but many were willing to catch up on all of them while there.
Countering Vaccine Misinformation in Clinical Practice with Amesh Adalja, MD: Primary Viewpoints Podcast
August 22, 2025
Infectious disease expert shares strategies for PCPs to counter vaccine myths, navigate policy changes, and build patient trust.
In Adults With Obesity, GLP-1 Receptor Agonists May Reduce Risk for Cancer
August 22, 2025
GLP-1 use was associated with lower overall cancer risk, with the strongest associations observed for endometrial and ovarian cancers and meningioma.
Upadacitinib Shows Significant Hair Regrowth in Second Phase 3 Trial for Severe Alopecia Areata
August 22, 2025
AbbVie reports that upadacitinib met primary and secondary endpoints, with up to 55% of patients achieving at least 80% scalp hair coverage at 24 weeks.
Head-To-Head Trial Shows Dynavax’s Z-1018 Rivals Shingrix for Efficacy and Tolerability
August 22, 2025
Z-1018, which combines a glycoprotein E (gE) antigen and proprietary adjuvant, was evaluated in adults aged 50 to 69 and the 100 µg dose will advance to part 2 of the trial.
Obesity and Venous Disease: Risk Factors and Key Diagnostic Challenges
August 21, 2025
Shagun Bindlish, MD, board member of the American Diabetes Association, discusses challenges to diagnosing and treating venous disease in patients with obesity.
With Medical Societies "Uninvited" From ACIP Vaccine Working Groups, Is There Any Hope for Harmonized Schedules?
August 21, 2025
William Schaffner, MD, a long-time liaison from the NFID to the ACIP working groups, is concerned about fragmentation of US vaccine recommendations.